Skip to main content

Table 2 Drugs and their concentrations used with cardiomyocytes derived from human embryonic and induced pluripotent stem cells

From: Effects of cardioactive drugs on human induced pluripotent stem cell derived long QT syndrome cardiomyocytes

Drug Concentrations
Isoprenaline nM: 81, 402
Cisapride monohydrate nM: 40, 83, 120, 165, 330
Erythromycin µM: 1.5, 3, 5.5, 8, 16
Sotalol µM: 0.8, 1.6, 5.7, 9.7, 19.4
Quinidine µM: 1.5, 3, 9, 15, 30
E-4031 nM: 10, 100, 300, 500, 700